TrialFrontiers in immunology2025

Efficacy and safety of the neoadjuvant chemoimmunotherapy with pembrolizumab plus docetaxel and cisplatin in resectable locally advanced squamous cell carcinoma of the head and neck.

Jing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.